39.49
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
Big Cap Pro
Monthly Subscription
for only
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
Level 1 Starter
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Rhythm Pharmaceuticals Inc | RYTM | NASDAQ | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
0.00 | 0.0% | 39.49 | 04:21:45 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
39.49 |
Bid Price | Ask Price | Spread | News | |
---|---|---|---|---|
39.49 | 41.29 | 1.80 | - | - |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 39.49 | USD |
Rhythm Pharmaceuticals Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 1.75B | 44.20M | 30.82M | $ - | $ - | -3.85 | -13.20 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | 0.00% | - | - |
Rhythm Pharmaceuticals News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RYTM Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 34.30 | 39.89 | 33.71 | 36.71 | 305,108 | 5.19 | 15.13% |
1 Month | 29.31 | 39.89 | 28.6843 | 33.03 | 324,390 | 10.18 | 34.73% |
3 Months | 22.64 | 39.89 | 20.56 | 29.14 | 390,596 | 16.85 | 74.43% |
6 Months | 20.93 | 39.89 | 18.00 | 27.27 | 330,571 | 18.56 | 88.68% |
1 Year | 17.50 | 39.89 | 12.99 | 23.77 | 275,478 | 21.99 | 125.66% |
3 Years | 30.20 | 39.89 | 12.99 | 24.92 | 212,724 | 9.29 | 30.76% |
5 Years | 23.21 | 39.89 | 12.99 | 25.22 | 218,525 | 16.28 | 70.14% |
Rhythm Pharmaceuticals Description
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. |